MedinCell secures additional 20 million euros financing with the European Investment Bank (EIB)

The approval obtained by the EIB is for a new credit facility of 40 million euros
The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB
30 million euros of the credit facility could be drawn in Q4 2022, and the disbursement of the remaining 10 million euros is subject to conditions that are expected to be met in 2023
Each tranche of the new credit facility will be reimbursed 5 years after drawdown
The signature of the new EIB credit facility is expected in a few weeks after finalization of the legal documentation